Innoviva, Inc. (FRA:HVE)

Innoviva Statistics

Total Valuation

Innoviva has a market cap or net worth of EUR 1.40 billion. The enterprise value is 1.22 billion.

Market Cap	1.40B
Enterprise Value	1.22B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.77M
Shares Outstanding	n/a
Shares Change (YoY)	+31.88%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	98.42%
Float	69.57M

Valuation Ratios

The trailing PE ratio is 12.91 and the forward PE ratio is 9.46.

PE Ratio	12.91
Forward PE	9.46
PS Ratio	4.23
PB Ratio	1.63
P/TBV Ratio	2.04
P/FCF Ratio	8.20
P/OCF Ratio	8.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.05, with an EV/FCF ratio of 7.14.

EV / Earnings	11.24
EV / Sales	3.64
EV / EBITDA	7.05
EV / EBIT	8.14
EV / FCF	7.14

Financial Position

The company has a current ratio of 14.12, with a Debt / Equity ratio of 0.32.

Current Ratio	14.12
Quick Ratio	12.93
Debt / Equity	0.32
Debt / EBITDA	1.61
Debt / FCF	1.61
Interest Coverage	9.58

Financial Efficiency

Return on equity (ROE) is 15.17% and return on invested capital (ROIC) is 8.60%.

Return on Equity (ROE)	15.17%
Return on Assets (ROA)	8.16%
Return on Invested Capital (ROIC)	8.60%
Return on Capital Employed (ROCE)	12.58%
Revenue Per Employee	2.61M
Profits Per Employee	854,609
Employee Count	127
Asset Turnover	0.29
Inventory Turnover	1.65

Taxes

In the past 12 months, Innoviva has paid 24.87 million in taxes.

Income Tax	24.87M
Effective Tax Rate	18.64%

Stock Price Statistics

The stock price has increased by +2.79% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.79%
50-Day Moving Average	16.41
200-Day Moving Average	16.65
Relative Strength Index (RSI)	59.99
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.76

Income Statement

In the last 12 months, Innoviva had revenue of EUR 331.14 million and earned 108.54 million in profits. Earnings per share was 1.30.

Revenue	331.14M
Gross Profit	279.94M
Operating Income	148.06M
Pretax Income	133.40M
Net Income	108.54M
EBITDA	170.46M
EBIT	148.06M
Earnings Per Share (EPS)	1.30

Balance Sheet

The company has 454.36 million in cash and 275.49 million in debt, giving a net cash position of 178.87 million.

Cash & Cash Equivalents	454.36M
Total Debt	275.49M
Net Cash	178.87M
Net Cash Per Share	n/a
Equity (Book Value)	860.78M
Book Value Per Share	11.51
Working Capital	542.15M

Cash Flow

In the last 12 months, operating cash flow was 171.87 million and capital expenditures -955,428, giving a free cash flow of 170.92 million.

Operating Cash Flow	171.87M
Capital Expenditures	-955,428
Free Cash Flow	170.92M
FCF Per Share	n/a

Margins

Gross margin is 84.54%, with operating and profit margins of 44.71% and 32.78%.

Gross Margin	84.54%
Operating Margin	44.71%
Pretax Margin	40.29%
Profit Margin	32.78%
EBITDA Margin	51.48%
EBIT Margin	44.71%
FCF Margin	51.61%

Dividends & Yields

Innoviva does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.88%
Shareholder Yield	-31.88%
Earnings Yield	7.75%
FCF Yield	12.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Innoviva has an Altman Z-Score of 3.01 and a Piotroski F-Score of 8.

Altman Z-Score	3.01
Piotroski F-Score	8